Hepatitis C Virus and the Host: A Mutual Endurance Leaving Indelible Scars in the Host's Immunity
- PMID: 38203436
- PMCID: PMC10779088
- DOI: 10.3390/ijms25010268
Hepatitis C Virus and the Host: A Mutual Endurance Leaving Indelible Scars in the Host's Immunity
Abstract
Hepatitis C virus (HCV) has spread worldwide, and it is responsible for potentially severe chronic liver disease and primary liver cancer. Chronic infection remains for life if not spontaneously eliminated and viral persistence profoundly impairs the efficiency of the host's immunity. Attempts have been made to develop an effective vaccine, but efficacy trials have met with failure. The availability of highly efficacious direct-acting antivirals (DAA) has created hope for the progressive elimination of chronic HCV infections; however, this approach requires a monumental global effort. HCV elicits a prompt innate immune response in the host, characterized by a robust production of interferon-α (IFN-α), although interference in IFN-α signaling by HCV proteins may curb this effect. The late appearance of largely ineffective neutralizing antibodies and the progressive exhaustion of T cells, particularly CD8 T cells, result in the inability to eradicate the virus in most infected patients. Moreover, an HCV cure resulting from DAA treatment does not completely restore the normal immunologic homeostasis. Here, we discuss the main immunological features of immune responses to HCV and the epigenetic scars that chronic viral persistence leaves behind.
Keywords: HCV; adaptive immunity; innate immunity.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Hepatitis C virus-specific immune responses following direct-acting antivirals administered during recent hepatitis C virus infection.J Viral Hepat. 2023 Jan;30(1):64-72. doi: 10.1111/jvh.13761. Epub 2022 Nov 13. J Viral Hepat. 2023. PMID: 36302162
-
Innate and adaptive immune responses in HCV infections.J Hepatol. 2014 Nov;61(1 Suppl):S14-25. doi: 10.1016/j.jhep.2014.06.035. Epub 2014 Nov 3. J Hepatol. 2014. PMID: 25443342 Review.
-
Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.J Hepatol. 2019 Nov;71(5):889-899. doi: 10.1016/j.jhep.2019.06.025. Epub 2019 Jul 8. J Hepatol. 2019. PMID: 31295532
-
Increased peripheral CD4+ regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C.J Hepatol. 2017 May;66(5):888-896. doi: 10.1016/j.jhep.2016.12.019. Epub 2016 Dec 29. J Hepatol. 2017. PMID: 28040549 Albanian, English.
-
Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.Cells. 2019 Apr 5;8(4):317. doi: 10.3390/cells8040317. Cells. 2019. PMID: 30959825 Free PMC article. Review.
Cited by
-
IFN-γ, IL-17, IL-22+ CD4+ subset in patients with hepatitis C virus and correlation with clinical factor.Am J Clin Exp Immunol. 2024 Feb 25;13(1):43-52. doi: 10.62347/DMJC6311. eCollection 2024. Am J Clin Exp Immunol. 2024. PMID: 38496355 Free PMC article.
-
Hepatocellular Carcinoma Incidences and Risk Factors in Hepatitis C Patients: Interferon versus Direct-Acting Agents.Viruses. 2024 Sep 18;16(9):1485. doi: 10.3390/v16091485. Viruses. 2024. PMID: 39339961 Free PMC article.
-
Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies.Pathogens. 2024 Sep 5;13(9):766. doi: 10.3390/pathogens13090766. Pathogens. 2024. PMID: 39338957 Free PMC article. Review.
References
-
- Ferrari C., Barili V., Varchetta S., Mondelli M.U. Immune mechanisms of viral clearance and disease pathogenesis during viral hepatitis. In: Arias I.M., Alter H.J., Boyer J.L., Cohen D.E., Shafritz D.A., Thorgeirsson S.S., Wolkoff A.W., editors. Liver Biology and Pathobiology. 6th ed. Wiley Blackwell; Oxford, UK: 2020. pp. 821–850.
-
- Barili V., Fisicaro P., Montanini B., Acerbi G., Filippi A., Forleo G., Romualdi C., Ferracin M., Guerrieri F., Pedrazzi G., et al. Targeting P53 and Histone Methyltransferases Restores Exhausted CD8+ T Cells in HCV Infection. Nat. Commun. 2020;11:604. doi: 10.1038/s41467-019-14137-7. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous